Breaking News Instant updates and real-time market news.

HAL

Halliburton

/

+

, BHI

BHI

/

+

08:32
07/23/15
07/23
08:32
07/23/15
08:32

Morgan Stanley says Halliburton antitrust story mostly noise

Morgan Stanley analyst Ole Slorer views yesterday's Bloomberg article suggesting Halliburton's (HAL) acquisition of Baker Hughes (BHI) faces antitrust hurdles in the U.S. as mostly noise. Slorer spoke with an antitrust expert and concluded the article summarized well known facts and came away with a more constructive view of the deal. The analyst said Halliburton's "exceptionally diligent" handling of the transaction has minimized risks. Slorer's team raised Halliburton's price target to $62 from $60 and Baker Hughes' to $88 from $86 and maintains Overweight ratings on both stocks.

HAL

Halliburton

/

+

BHI

BHI

/

+

HAL Halliburton
/

+

07/23/15 Deutsche Bank
Deutsche sees little new in Bloomberg story on Halliburton
07/22/15 Evercore ISI
Baker Hughes weakness a buying opportunity, says Evercore ISI
07/21/15
On The Fly: Analyst Upgrade Summary
07/21/15 Seaport Global
Halliburton upgraded to Accumulate from Neutral at Global Hunter
BHI BHI
/

+

07/22/15 Susquehanna
Baker Hughes results suggest prolong recovery, says Susquehanna
07/21/15 Citi
Halliburton has 90% upside potential over 3 years, says Citi

TODAY'S FREE FLY STORIES

Recommendations
Couchbase price target lowered to $44 from $50 at Oppenheimer » 08:27
12/08/21
12/08
08:27
12/08/21
08:27
BASE

Couchbase

$29.50 /

+3.5 (+13.46%)

Oppenheimer analyst Ittai…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BASE Couchbase
$29.50 /

+3.5 (+13.46%)

06:17 Today Barclays
Couchbase price target lowered to $41 from $52 at Barclays
12/06/21 RBC Capital
Couchbase price target lowered to $43 from $53 at RBC Capital
09/09/21 Oppenheimer
Couchbase price target raised to $50 from $40 at Oppenheimer
09/09/21 Baird
Couchbase price target raised to $50 from $43 at Baird
BASE Couchbase
$29.50 /

+3.5 (+13.46%)

  • 22
    Jul
BASE Couchbase
$29.50 /

+3.5 (+13.46%)

Conference/Events
BorgWarner management to meet virtually with Wolfe Research » 08:27
12/08/21
12/08
08:27
12/08/21
08:27
BWA

BorgWarner

$45.55 /

+0.735 (+1.64%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BWA BorgWarner
$45.55 /

+0.735 (+1.64%)

BWA BorgWarner
$45.55 /

+0.735 (+1.64%)

11/04/21 Deutsche Bank
BorgWarner added to 'short-term Catalyst Call Buy List' at Deutsche Bank
10/27/21 Cowen
Romeo Power downgraded to Market Perform from Outperform at Cowen
10/22/21 Morgan Stanley
Proterra initiated with an Equal Weight at Morgan Stanley
09/26/21 Goldman Sachs
BorgWarner price target lowered to $47 from $48 at Goldman Sachs
BWA BorgWarner
$45.55 /

+0.735 (+1.64%)

BWA BorgWarner
$45.55 /

+0.735 (+1.64%)

Hot Stocks
Calibre files special meeting materials on proposed Fiore Gold transaction » 08:26
12/08/21
12/08
08:26
12/08/21
08:26
CXBMF

Calibre Mining

$1.00 /

+0.0129 (+1.31%)

, FIOGF

Fiore Gold

$1.02 /

+0.017 (+1.69%)

Calibre Mining announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CXBMF Calibre Mining
$1.00 /

+0.0129 (+1.31%)

CXBMF Calibre Mining
$1.00 /

+0.0129 (+1.31%)

10/13/21 Raymond James
Calibre Mining price target lowered to C$2.50 from C$2.75 at Raymond James
04/06/21 Scotiabank
Calibre Mining price target lowered to C$2.75 from C$3 at Scotiabank
03/29/21 BMO Capital
Calibre Mining upgraded to Outperform from Market Perform at BMO Capital
01/14/21 BMO Capital
Calibre Mining initiated with a Market Perform at BMO Capital
FIOGF Fiore Gold
$1.02 /

+0.017 (+1.69%)

02/08/21 Stifel
Fiore Gold price target lowered to C$2.40 from C$2.55 at Stifel
Recommendations
Tower Semiconductor price target raised to $46 from $42 at Jefferies » 08:26
12/08/21
12/08
08:26
12/08/21
08:26
TSEM

Tower Semiconductor

$38.50 /

+0.05 (+0.13%)

Jefferies analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSEM Tower Semiconductor
$38.50 /

+0.05 (+0.13%)

TSEM Tower Semiconductor
$38.50 /

+0.05 (+0.13%)

11/09/21 Craig-Hallum
Tower Semiconductor price target raised to $50 from $40 at Craig-Hallum
02/18/21 Craig-Hallum
Tower Semiconductor price target raised to $40 from $35 at Craig-Hallum
02/01/21 Craig-Hallum
Tower Semiconductor price target raised to $35 from $27 at Craig-Hallum
01/19/21 Credit Suisse
Tower Semiconductor upgraded to Outperform from Neutral at Credit Suisse
TSEM Tower Semiconductor
$38.50 /

+0.05 (+0.13%)

TSEM Tower Semiconductor
$38.50 /

+0.05 (+0.13%)

Hot Stocks
Celldex announces first patient dosed in Phase 1 study of CDX-0159 » 08:26
12/08/21
12/08
08:26
12/08/21
08:26
CLDX

Celldex

$38.77 /

+2.39 (+6.57%)

Celldex Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLDX Celldex
$38.77 /

+2.39 (+6.57%)

CLDX Celldex
$38.77 /

+2.39 (+6.57%)

09/17/21 Jefferies
Celldex initiated with a Buy at Jefferies
09/13/21 H.C. Wainwright
Celldex price target raised to $60 from $54 at H.C. Wainwright
09/10/21 SVB Leerink
SVB Leerink starts Celldex with Outperform on 'blockbuster opportunity'
09/10/21 SVB Leerink
Celldex initiated with an Outperform at SVB Leerink
CLDX Celldex
$38.77 /

+2.39 (+6.57%)

  • 14
    Jul
CLDX Celldex
$38.77 /

+2.39 (+6.57%)

Technical Analysis
Nasdaq 100 Index: Pivot points » 08:26
12/08/21
12/08
08:26
12/08/21
08:26
NDX

Nasdaq 100 Index

/

+

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NDX Nasdaq 100 Index
/

+

NDX Nasdaq 100 Index
/

+

Recommendations
Neurocrine price target raised to $154 from $140 at Oppenheimer » 08:26
12/08/21
12/08
08:26
12/08/21
08:26
NBIX

Neurocrine

$82.31 /

+1.68 (+2.08%)

Oppenheimer analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NBIX Neurocrine
$82.31 /

+1.68 (+2.08%)

NBIX Neurocrine
$82.31 /

+1.68 (+2.08%)

06:23 Today Citi
Neurocrine price target raised to $129 from $127 at Citi
11/18/21 BMO Capital
Neurocrine initiated with an Underperform at BMO Capital
11/17/21
Fly Intel: Top five analyst upgrades
11/17/21 JPMorgan
Neurocrine upgraded to Overweight from Neutral at JPMorgan
NBIX Neurocrine
$82.31 /

+1.68 (+2.08%)

NBIX Neurocrine
$82.31 /

+1.68 (+2.08%)

Hot Stocks
OncoCyte, Burning Rock complete second part of technology transfer » 08:25
12/08/21
12/08
08:25
12/08/21
08:25
OCX

OncoCyte

$2.40 /

+0.09 (+3.90%)

Oncocyte Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCX OncoCyte
$2.40 /

+0.09 (+3.90%)

OCX OncoCyte
$2.40 /

+0.09 (+3.90%)

04/12/21 Lake Street
AACR data strengthens 'pan-cancer credentials' for OncoCyte, says Lake Street
04/12/21 Piper Sandler
OncoCyte remains a top pick small-cap pick at Piper Sandler
03/30/21 Piper Sandler
OncoCyte called 'top small-cap pick' at Piper Sandler
03/17/21
Fly Intel: Top five analyst initiations
OCX OncoCyte
$2.40 /

+0.09 (+3.90%)

  • 05
    Feb
Recommendations
AeroVironment price target lowered to $65 from $95 at RBC Capital » 08:24
12/08/21
12/08
08:24
12/08/21
08:24
AVAV

AeroVironment

$57.91 /

-22.02 (-27.55%)

RBC Capital analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVAV AeroVironment
$57.91 /

-22.02 (-27.55%)

AVAV AeroVironment
$57.91 /

-22.02 (-27.55%)

07:01 Today Baird
AeroVironment price target lowered to $72 from $120 at Baird
06:54 Today Canaccord
Canaccord downgrades AeroVironment, more than halves target after guidance cut
05:42 Today Canaccord
AeroVironment downgraded to Hold from Buy at Canaccord
10/21/21 RBC Capital
AeroVironment initiated with a Sector Perform at RBC Capital
AVAV AeroVironment
$57.91 /

-22.02 (-27.55%)

AVAV AeroVironment
$57.91 /

-22.02 (-27.55%)

AVAV AeroVironment
$57.91 /

-22.02 (-27.55%)

Recommendations
Carlisle price target raised to $270 from $255 at Oppenheimer » 08:23
12/08/21
12/08
08:23
12/08/21
08:23
CSL

Carlisle

$241.86 /

+2.375 (+0.99%)

Oppenheimer analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSL Carlisle
$241.86 /

+2.375 (+0.99%)

CSL Carlisle
$241.86 /

+2.375 (+0.99%)

11/15/21 Zelman
Carlisle initiated with a Buy at Zelman
10/22/21 Baird
Carlisle price target raised to $250 from $240 at Baird
10/11/21 Baird
Carlisle price target raised to $240 from $230 at Baird
08/30/21 Oppenheimer
Carlisle price target raised to $250 from $230 at Oppenheimer
CSL Carlisle
$241.86 /

+2.375 (+0.99%)

Hot Stocks
Talis Biomedical CEO Blaser steps down, CCO Kelley to succeed » 08:22
12/08/21
12/08
08:22
12/08/21
08:22
TLIS

Talis Biomedical

$4.81 /

-0.02 (-0.41%)

Talis Biomedical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TLIS Talis Biomedical
$4.81 /

-0.02 (-0.41%)

TLIS Talis Biomedical
$4.81 /

-0.02 (-0.41%)

09/27/21 JPMorgan
Talis Biomedical downgraded to Underweight from Neutral at JPMorgan
08/31/21 BTIG
Talis Biomedical downgraded to Neutral at BTIG following CEO departure
08/31/21 BTIG
Talis Biomedical downgraded to Neutral from Buy at BTIG
08/12/21 Piper Sandler
Talis Biomedical downgraded to Neutral from Overweight at Piper Sandler
TLIS Talis Biomedical
$4.81 /

-0.02 (-0.41%)

  • 12
    Feb
TLIS Talis Biomedical
$4.81 /

-0.02 (-0.41%)

Hot Stocks
DavidsTea partners with wellness, sleep tracking app BetterSleep » 08:22
12/08/21
12/08
08:22
12/08/21
08:22
DTEA

DavidsTea

$3.60 /

+0.045 (+1.27%)

DAVIDsTEA announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DTEA DavidsTea
$3.60 /

+0.045 (+1.27%)

DTEA DavidsTea
$3.60 /

+0.045 (+1.27%)

DTEA DavidsTea
$3.60 /

+0.045 (+1.27%)

DTEA DavidsTea
$3.60 /

+0.045 (+1.27%)

Hot Stocks
PAE achieves certifications for occupational health, safety management systems » 08:21
12/08/21
12/08
08:21
12/08/21
08:21
PAE

PAE

$9.90 /

+ (+0.00%)

PAE announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PAE PAE
$9.90 /

+ (+0.00%)

PAE PAE
$9.90 /

+ (+0.00%)

09/20/21 BofA
BofA starts PAE at Buy, says pullback on Middle East exposure 'excessive'
09/20/21 BofA
PAE initiated with a Buy at BofA
08/25/21
Fly Intel: Top five analyst downgrades
08/25/21 Morgan Stanley
PAE downgraded to Equal Weight from Overweight at Morgan Stanley
PAE PAE
$9.90 /

+ (+0.00%)

PAE PAE
$9.90 /

+ (+0.00%)

Hot Stocks
Bionano Genomics announces publication of study on OGM to treat MDS » 08:20
12/08/21
12/08
08:20
12/08/21
08:20
BNGO

Bionano Genomics

$3.62 /

+0.28 (+8.40%)

Bionano Genomics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BNGO Bionano Genomics
$3.62 /

+0.28 (+8.40%)

BNGO Bionano Genomics
$3.62 /

+0.28 (+8.40%)

06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
BNGO Bionano Genomics
$3.62 /

+0.28 (+8.40%)

  • 20
    Jan
  • 08
    Jan
BNGO Bionano Genomics
$3.62 /

+0.28 (+8.40%)

Hot Stocks
Marrone Bio says MBI-306 demonstrates substantial yield gains in trials » 08:20
12/08/21
12/08
08:20
12/08/21
08:20
MBII

Marrone Bio

/

+

Field trials in 2021 for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MBII Marrone Bio
/

+

MBII Marrone Bio
/

+

09/22/21 Roth Capital
Marrone Bio initiated with a Buy at Roth Capital
05/14/21 Lake Street
Marrone Bio weakness a buying opportunity, says Lake Street
03/24/21 H.C. Wainwright
Marrone Bio price target raised to $4 from $2.50 at H.C. Wainwright
02/19/21 Canaccord
Marrone Bio price target raised to $3.50 from $2 at Canaccord
MBII Marrone Bio
/

+

Initiation
Allot Ltd. initiated with an Outperform at Northland » 08:19
12/08/21
12/08
08:19
12/08/21
08:19
ALLT

Allot Ltd.

$11.14 /

+0.41 (+3.82%)

Northland analyst Nehal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALLT Allot Ltd.
$11.14 /

+0.41 (+3.82%)

ALLT Allot Ltd.
$11.14 /

+0.41 (+3.82%)

11/11/21 BofA
Allot Ltd. downgraded to Neutral from Buy at BofA
11/11/21 BofA
Allot Ltd. downgraded to Neutral from Buy at BofA
11/10/21 Lake Street
Allot Ltd. price target lowered to $16 from $21 at Lake Street
06/08/21 Lake Street
Allot Ltd. price target raised to $22 from $20 at Lake Street
ALLT Allot Ltd.
$11.14 /

+0.41 (+3.82%)

ALLT Allot Ltd.
$11.14 /

+0.41 (+3.82%)

Hot Stocks
Ocuphire Pharma expands MAB with six new KOLs » 08:18
12/08/21
12/08
08:18
12/08/21
08:18
OCUP

Ocuphire Pharma

$3.79 /

+0.31 (+8.91%)

Ocuphire Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCUP Ocuphire Pharma
$3.79 /

+0.31 (+8.91%)

OCUP Ocuphire Pharma
$3.79 /

+0.31 (+8.91%)

11/24/21 H.C. Wainwright
Ocuphire Pharma initiated with a Buy at H.C. Wainwright
10/06/21 Spartan Capital
Ocuphire Pharma initiated with a Buy at Spartan Capital
06/01/21 JonesTrading
Jones Trading bullish on Ocuphire, sees 'under the radar' revenue opportunity
04/05/21 Alliance Global Partners
Ocuphire Pharma initiated with a Buy at Alliance Global Partners
OCUP Ocuphire Pharma
$3.79 /

+0.31 (+8.91%)

OCUP Ocuphire Pharma
$3.79 /

+0.31 (+8.91%)

OCUP Ocuphire Pharma
$3.79 /

+0.31 (+8.91%)

Syndicate
Oriental Culture Holding signs Securities Purchase Agreements with two investors » 08:18
12/08/21
12/08
08:18
12/08/21
08:18
OCG

Oriental Culture Holding

$3.96 /

-0.16 (-3.88%)

Oriental Culture Holding…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCG Oriental Culture Holding
$3.96 /

-0.16 (-3.88%)

OCG Oriental Culture Holding
$3.96 /

-0.16 (-3.88%)

Hot Stocks
Corcept Therapeutics announces extension of previously announced tender offer » 08:17
12/08/21
12/08
08:17
12/08/21
08:17
CORT

Corcept Therapeutics

$21.92 /

-0.32 (-1.44%)

Corcept Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CORT Corcept Therapeutics
$21.92 /

-0.32 (-1.44%)

CORT Corcept Therapeutics
$21.92 /

-0.32 (-1.44%)

CORT Corcept Therapeutics
$21.92 /

-0.32 (-1.44%)

Hot Stocks
Converge Technology announces increase to credit facility » 08:16
12/08/21
12/08
08:16
12/08/21
08:16
CTSDF

Converge Technology

$9.37 /

+0.69 (+7.95%)

Converge Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSDF Converge Technology
$9.37 /

+0.69 (+7.95%)

CTSDF Converge Technology
$9.37 /

+0.69 (+7.95%)

11/15/21 Canaccord
Converge Technology price target lowered to C$13 from C$14 at Canaccord
11/15/21 Berenberg
Converge Technology initiated with a Buy at Berenberg
11/12/21 Scotiabank
Converge Technology price target lowered to C$13 from C$14 at Scotiabank
10/19/21 Scotiabank
Converge Technology initiated with an Outperform at Scotiabank
Periodicals
Tesla sold 52.86K China-made vehicles in November, Reuters reports » 08:16
12/08/21
12/08
08:16
12/08/21
08:16
TSLA

Tesla

$1,051.18 /

+42.645 (+4.23%)

According to China…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$1,051.18 /

+42.645 (+4.23%)

TSLA Tesla
$1,051.18 /

+42.645 (+4.23%)

12/07/21 UBS
Tesla price target raised to $1,000 from $725 at UBS
12/06/21 RBC Capital
Tesla price target raised to $950 from $800 at RBC Capital
12/06/21 Wedbush
Wedbush initiates Rivian Automotive with an Outperform, $130 price target
12/06/21 Wolfe Research
Rivian Automotive initiated with an Outperform at Wolfe Research
TSLA Tesla
$1,051.18 /

+42.645 (+4.23%)

TSLA Tesla
$1,051.18 /

+42.645 (+4.23%)

TSLA Tesla
$1,051.18 /

+42.645 (+4.23%)

TSLA Tesla
$1,051.18 /

+42.645 (+4.23%)

Hot Stocks
McKesson announces $4B share repurchase program increase  08:16
12/08/21
12/08
08:16
12/08/21
08:16
MCK

McKesson

$224.50 /

+0.49 (+0.22%)

 
ShowHide Related Items >><<
MCK McKesson
$224.50 /

+0.49 (+0.22%)

MCK McKesson
$224.50 /

+0.49 (+0.22%)

12/06/21 Cowen
McKesson price target raised to $300 from $268 at Cowen
11/08/21 Argus
McKesson price target raised to $270 from $230 at Argus
11/05/21 Cowen
McKesson price target raised to $268 from $247 at Cowen
11/03/21 Deutsche Bank
McKesson price target raised to $279 from $261 at Deutsche Bank
MCK McKesson
$224.50 /

+0.49 (+0.22%)

MCK McKesson
$224.50 /

+0.49 (+0.22%)

MCK McKesson
$224.50 /

+0.49 (+0.22%)

MCK McKesson
$224.50 /

+0.49 (+0.22%)

Hot Stocks
Campbell Soup sees 'difficult' comparison in Q2, but 'positive' 2H performance  08:16
12/08/21
12/08
08:16
12/08/21
08:16
CPB

Campbell Soup

$41.14 /

-0.1599 (-0.39%)

 
ShowHide Related Items >><<
CPB Campbell Soup
$41.14 /

-0.1599 (-0.39%)

CPB Campbell Soup
$41.14 /

-0.1599 (-0.39%)

11/23/21 Deutsche Bank
Campbell Soup price target lowered to $44 from $48 at Deutsche Bank
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
09/02/21 RBC Capital
Campbell Soup price target lowered to $54 from $59 at RBC Capital
09/02/21 BofA
Campbell Soup price target lowered to $42 from $45 at BofA
CPB Campbell Soup
$41.14 /

-0.1599 (-0.39%)

CPB Campbell Soup
$41.14 /

-0.1599 (-0.39%)

CPB Campbell Soup
$41.14 /

-0.1599 (-0.39%)

CPB Campbell Soup
$41.14 /

-0.1599 (-0.39%)

Earnings
McKesson raises FY22 adjusted EPS view to $22.35-$22.95 from $21.95-$22.55 » 08:15
12/08/21
12/08
08:15
12/08/21
08:15
MCK

McKesson

$224.50 /

+0.49 (+0.22%)

Consensus $22.42.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCK McKesson
$224.50 /

+0.49 (+0.22%)

MCK McKesson
$224.50 /

+0.49 (+0.22%)

12/06/21 Cowen
McKesson price target raised to $300 from $268 at Cowen
11/08/21 Argus
McKesson price target raised to $270 from $230 at Argus
11/05/21 Cowen
McKesson price target raised to $268 from $247 at Cowen
11/03/21 Deutsche Bank
McKesson price target raised to $279 from $261 at Deutsche Bank
MCK McKesson
$224.50 /

+0.49 (+0.22%)

MCK McKesson
$224.50 /

+0.49 (+0.22%)

MCK McKesson
$224.50 /

+0.49 (+0.22%)

MCK McKesson
$224.50 /

+0.49 (+0.22%)

Hot Stocks
Veru announces presentation of data on enobosarm treatment » 08:15
12/08/21
12/08
08:15
12/08/21
08:15
VERU

Veru

$6.36 /

+0.175 (+2.83%)

Veru announced that human…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VERU Veru
$6.36 /

+0.175 (+2.83%)

VERU Veru
$6.36 /

+0.175 (+2.83%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VERU Veru
$6.36 /

+0.175 (+2.83%)

  • 18
    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.